| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/13/2005 | CA2531360A1 Methods of producing differentiated hematopoietic cells for treatment of cytopenia |
| 01/13/2005 | CA2531081A1 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 01/13/2005 | CA2530794A1 Agent for preventing and curing pathological states associated with endorphin deficiency in organism |
| 01/13/2005 | CA2530533A1 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
| 01/13/2005 | CA2530509A1 A method and agents for improving plant productivity involving endophytic actinomycetes and metabolites thereof |
| 01/13/2005 | CA2530490A1 Conditioned matrix compositions for tissue restoration |
| 01/13/2005 | CA2529244A1 Rapamycin resistant t cells and therapeutic uses thereof |
| 01/12/2005 | EP1496364A2 Cloning and expression of gonadotropin-releasing hormone receptor |
| 01/12/2005 | EP1496109A1 Process for producing cytotoxic lymphocyte |
| 01/12/2005 | EP1496060A1 Antitumoral analogs of ET-743 |
| 01/12/2005 | EP1495141A2 Hiv therapeutic |
| 01/12/2005 | EP1495140A1 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases |
| 01/12/2005 | EP1495122A1 Antiviral therapy on the basis of rna interference |
| 01/12/2005 | EP1495111A2 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 01/12/2005 | EP1495110A1 Recombinant spores |
| 01/12/2005 | EP1495109A1 Method of preparing a probiotic preparation |
| 01/12/2005 | EP1494723A1 Methods and apparatus for decontaminating fluids |
| 01/12/2005 | EP1494705A1 A composition and method for killing of tumours |
| 01/12/2005 | EP1494687A2 Immunomodulatory polymeric antigens for treating inflammatory pathogies |
| 01/12/2005 | EP1494665A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease |
| 01/12/2005 | EP1494651A2 Preservation of bioactive materials by freeze dried foam |
| 01/12/2005 | EP1494638A1 Compositions and methods for inducing new hair follicle formation and hair growth in a desired orientation |
| 01/12/2005 | EP1494613A2 Potent oncolytic herpes simplex virus for cancer therapy |
| 01/12/2005 | EP1494539A1 Cheese capable of disinfecting helicobacter pylori |
| 01/12/2005 | EP1494535A2 Compositions and minimally invasive methods for treating incomplete tissue repair |
| 01/12/2005 | EP1313494B1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain |
| 01/12/2005 | EP1282407A4 Delivery mechanism for the introduction of biological substances to animals |
| 01/12/2005 | EP1242157B1 Methods for preparing blood or plasma component solutions with improved concentrations |
| 01/12/2005 | EP1192245B1 Methods for the propagation of lytic organisms |
| 01/12/2005 | EP1083930A4 Insulin supplemented infant formula |
| 01/12/2005 | EP1077711B1 Treatment of papilloma virus infection using a mycobacterium |
| 01/12/2005 | EP0988860B1 Use of a-glycosylceramides for the manufacture of a therapeutic agent for autoimmune diseases |
| 01/12/2005 | EP0828499B1 Micro-encapsulated lactobacilli for medical applications |
| 01/12/2005 | CN1564696A Compositions for and methods of treating and preventing sirs/sepsis |
| 01/12/2005 | CN1564692A Fever bringing down formulating for preventing virus and its prepn. method |
| 01/12/2005 | CN1564678A Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 01/12/2005 | CN1563393A Method for preparing natural bezoar promoted by enzyme |
| 01/12/2005 | CN1562375A Combination of medication produced from attenuated salmonella bacteria possessing effect of radiation protection and anti tumour |
| 01/12/2005 | CN1562339A Method for preparing pharmaceutics of hydrolysate of brain protein |
| 01/12/2005 | CN1562167A Medication for curing disease of stomach intestine |
| 01/12/2005 | CN1562087A Amphioxus preparation for treating lung cancer, chronic bronchitis and bronchial asthma, and preparing method |
| 01/12/2005 | CN1562086A Method for extracting bee essence from bee embryo |
| 01/12/2005 | CN1562085A Odontitis tincture and its preparing method |
| 01/12/2005 | CN1562084A Method for preparing silkworm powder and its use |
| 01/12/2005 | CN1562083A Method for preparing musk freeze-dried powder injection |
| 01/12/2005 | CN1562082A Ass-hide glue phosphotipid composition and its preparing method |
| 01/12/2005 | CN1562081A Process for preparing livestock animal brain fat composite medicine |
| 01/12/2005 | CN1184321C Adenovirus-mediated gene therapy |
| 01/12/2005 | CN1184308C Prepn process of live lactic and butyric acid bucillus product |
| 01/12/2005 | CN1184307C Industrial fermenting process of sphaeroid red bacteria and its fermented liquid |
| 01/12/2005 | CN1183953C Medicine for clearnig away heat and toxic matter, promoting diuresis and stopping itching |
| 01/12/2005 | CN1183946C Medicines for treating depression and preparation thereof |
| 01/12/2005 | CN1183942C Chinese medicine pill for treating cough |
| 01/12/2005 | CN1183941C Chinese medicinal liquid pill for treating cardio-cerebral angiopathy |
| 01/12/2005 | CN1183938C Chinese medicine prepn for expelling toxin and resisting cancer and its preparing method and use |
| 01/12/2005 | CN1183937C Compound Chinese medicine preparation of damnacanthus for treating hepatitis B |
| 01/12/2005 | CN1183932C Patent Chinese medicine and preparing process for deficiency syndrome |
| 01/12/2005 | CN1183931C Medicine for treating kidney disease |
| 01/12/2005 | CN1183930C Bone-setting medicine and its preparing process |
| 01/12/2005 | CN1183929C Medicine for curing prolapse of lumbar intervertebral disc and its preparation method |
| 01/12/2005 | CN1183928C Chinese medicinal powder for resisting thrombosis and its preparation method |
| 01/12/2005 | CN1183927C Capsule for treating lumbocrural pain, prolapse of lumbar intervertebral disc and rheumatism bone pain |
| 01/12/2005 | CN1183926C Cigarette for dropping drug and its preparing process |
| 01/12/2005 | CN1183925C Externally-used paste for curing burn, scald and electric shock wound |
| 01/12/2005 | CN1183922C Medicine for treating postoperative adhesion and its preparing process |
| 01/12/2005 | CN1183920C Medicine for treating neurosis via head acupoint osmosis |
| 01/12/2005 | CN1183919C Cancer treating medical composition |
| 01/12/2005 | CN1183918C Medicine for curing protrution of intervetebral disc |
| 01/12/2005 | CN1183917C Dermatosis treating ointment |
| 01/12/2005 | CN1183916C Use of lactic acid bacterium for the treatment of peritonitis |
| 01/12/2005 | CN1183839C Sobering-up and drunkeness-preventing liver protective beverage containing dehydrogenase |
| 01/11/2005 | US6841542 Transforming growth factor beta (TGF-β) blocking agent-treated stem cell composition and method |
| 01/11/2005 | US6841381 Immunization by inoculation of DNA transcription unit |
| 01/11/2005 | US6841180 Method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby |
| 01/11/2005 | US6841171 Obtained by subjecting oyster flesh to the action of a protease under suitable conditions exhibit a free-radical scavenging activity which is even higher than that observed for the aqueous oyster extracts |
| 01/11/2005 | US6841170 Using as the activator batroxobin in place of thrombin |
| 01/11/2005 | US6841151 Chondrocyte cells for use in the treatment of arthritic and bone disorders |
| 01/11/2005 | US6841150 Incubating with chondroinductive agent that activates cellular transduction leading to mature phenotype, antibiotic, fetal bovine serum or horse serum, vitamin C, and glucocorticoid |
| 01/11/2005 | US6841149 Controlling or inhibiting the colonization of deleterious bacteria in the intestines of monogastric animals and humans, comprising: Enterococcus strains; Saccharomyces strains; and carbohydrate source |
| 01/11/2005 | CA2267670C Method for preparing human stem cell factor polypeptide |
| 01/11/2005 | CA2248235C Use of honey as an agent to reduce the adhesion of microorganisms |
| 01/07/2005 | CA2434995A1 Oncolytic viruses for the treatment of neoplasms having activated pp2a or rac |
| 01/06/2005 | WO2005001732A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
| 01/06/2005 | WO2005001092A2 Compositions and methods for diagnosing and treating cancers |
| 01/06/2005 | WO2005001080A2 Postpartum-derived cells for use in treatment of disease of the heart and circulatory system |
| 01/06/2005 | WO2005001079A2 Soft tissue repair and regeneration using postpartum-derived cells |
| 01/06/2005 | WO2005001078A2 Regeneration and repair of neural tissue using postpartum-derived cells |
| 01/06/2005 | WO2005001077A2 Repair and regeneration of ocular tissue using postpartum-derived cells |
| 01/06/2005 | WO2005001076A2 Postpartum cells derived from placental tissue, and methods of making and using the same |
| 01/06/2005 | WO2005001073A1 Method for differentiating stem cells in cells that produce a pancreatic hormone |
| 01/06/2005 | WO2005001072A1 Isolated pluripotent adult stem cells and methods for isolating and cultivating the same |
| 01/06/2005 | WO2005001054A2 Methods of producing neurons |
| 01/06/2005 | WO2005001042A2 Smooth muscle progenitor cells |
| 01/06/2005 | WO2005000890A1 Method for transplanting lymphohematopoietic cells into mammal |
| 01/06/2005 | WO2005000344A2 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
| 01/06/2005 | WO2005000342A1 Peptides derived from the protein mmp-2, and the use thereof in antitumoral immunotherapy |
| 01/06/2005 | WO2005000327A2 Use of bacilli bacteria in order to produce a composition for the prevention of vertebral compression syndrome in salmonids |
| 01/06/2005 | WO2005000326A1 Pharmaceutical slimming agent |
| 01/06/2005 | WO2005000325A2 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 01/06/2005 | WO2005000322A1 Process for restoring the cell balance in living beings |